TAG:
pathology groups
Changing the Way Laboratories Do Business
By R. Lewis Dark | From the Volume X No. 12 – September 8, 2003 Issue
I HOPE BOTH PATHOLOGISTS AND LABORATORY ADMINISTRATORS pay close attention to our coverage of early-adopter hospital laboratories and how they are using “Lean” quality management methods to boost performance of their laboratories. These labs are harvesting productivity gains in the range of 30% t…
How “Lean” is Benefiting Early-Adopter Laboratories
By Robert Michel | From the Volume X No. 12 – September 8, 2003 Issue
CEO SUMMARY: First steps toward a radical change in clinical laboratory operations are under way in a handful of early-adopter laboratories. This movement is so new that little information about their successes can be published. But the early evidence is compelling. For those labs willing…
Major Events Hit Pathology Profession
By R. Lewis Dark | From the Volume X No. 11 – August 18, 2003 Issue
ACROSS THE AMERICAN HEALTHCARE SYSTEM, numerous trends tug at pathologists and the laboratory medicine services they provide. Both clinical pathologists and anatomic pathologists find themselves confronted with a growing number of demands for change. Increasingly these demands can no longer be ignore…
First ISO-Designed Clinical Lab Improves Outcomes, Costs
By Robert Michel | From the Volume X No. 11 – August 18, 2003 Issue
CEO SUMMARY: In the first 14 months of operation, Kaiser Permanente Northwest’s new automated regional laboratory facility, the nation’s first designed by an ISO-9000-certified lab organization, is yielding big gains in both productivity and outcomes. In its high-volume core lab, prod…
Pathology Group Conflicts Over Equity Vs. Salary
By Robert Michel | From the Volume X No. 11 – August 18, 2003 Issue
CEO SUMMARY: During the next two years, two of every three pathology group practices will see a change in pathologists, either through new hires or by resignation and retirement. These events fundamentally change the financial situation of the group, but since most groups are organized un…
Genomic Health, LabCorp, DIANON Systems
By Robert Michel | From the Volume X No. 8 – June 16, 2003 Issue
GENETIC ANALYSIS FROM TISSUE BLOCKS UNVEILED IN CHICAGO IT WAS A SPECTACULAR DEBUT for a Northern California company now developing technology to allow genetic analysis of tissue blocks as a way to classify tumors. The company is Genomic Health, Inc., based in Redwood City,…
‘Health Lawyers News’ Attacks Pathology Part A
By Robert Michel | From the Volume X No. 7 – May 27, 2003 Issue
CEO SUMMARY: Pathologists should take time to read the cover story in the May 2003 issue of Health Lawyers News. Although the story nominally addresses questions involving how hospitals should reimburse physicians for administrative duties, it deals mostly with clinical pathology…
Specialty Laboratories, IMPATH, Roche, Abbott Laboratories, Celera Diagnostics
By Robert Michel | From the Volume X No. 6 – May 5, 2003 Issue
SPECIALTY LABORATORIES RESTORING STABILITY IN SPECIMEN VOLUME IT’S NO SURPRISE THAT COMPETITORS of Specialty Laboratories, Inc. have been willing to spread a variety of rumors about the laboratory company, given its well-publicized troubles with government regulators last …
LabCorp’s MacMahon Provides Insights About Lab Marketplace
By Robert Michel | From the Volume X No. 5 – April 14, 2003 Issue
CEO SUMMARY: Pathologists will be particularly interested in what Thomas MacMahon has to say about the evolution of laboratory medicine. As Chairman, President, and CEO of Laboratory Corporation of America Holdings, he has continuous access to some of the best strategic analysis about the…
Buyout of AmeriPath Riles Some Shareholders
By Robert Michel | From the Volume X No. 3 – March 3, 2003 Issue
CEO SUMMARY: Owners of the few remaining independent private laboratory companies closely watch prices paid by lab buyers. In the pending sale of AmeriPath to private equity investor Welsh, Carson, Anderson, & Stowe, dissenting shareholders disclosed several aspects of the valuation p…
CURRENT ISSUE
Volume XXXII, No. 15 – October 27, 2025
The Dark Report examines the momentous decision by the VA to switch accreditors from The Joint Commission to CAP. Also, we analyze retractions in pathology journals to gain insight into scientific fraud.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized